Table 4.
The comparison of hTERC amplification at pre- and post-operation among patients with normal 2-year follow-up
| Pathologic Diagnosis | N | Percentage of positive cells (± SD%) | Incidence of positive cases (number incident cases/total) | ||
|---|---|---|---|---|---|
| |
|
Pre-operation |
Post-operation |
Pre-operation |
Post-operation |
| CIN LEEP |
11 |
11.2 ± 4.1 |
7.2 ± 2.7* |
72.7% (8/11) |
18.2%* (2/11)* |
| Radical hysterectomy | 14 | 45.7 ± 21.6 | 7.1 ± 2.0* | 100% (14/14) | 14.3%* (2 /14) |
hTERC, human telomerase mRNA component gene; CIN, cervical intraepithelial neoplasia; LEEP, loop electrical excision procedure. *P < 0.05 (compared with pre-operation).